None listed
Conditions
Brief summary
Hallux Rigidus is the most common arthritic condition of the foot, causing pain and stiffness of the 1st metatarsophalangeal (MTP) joint. Consideration of surgical management following failure of nonoperative treatment is based on multiple factors including age and activity level of the patient, as well as the severity of the arthritis. An arthrodesis of this joint is regarded as the gold standard for treatment of end stage hallux rigidus. The goal of this procedure is to relieve pain and improve functional status. Our study aims to collect information regarding the outcomes of surgery from a patients perspective. This information will allow surgeons to ensure that patients are fully informed of the implications of surgery.
Interventions
Patients outcomes following 1st metatarsophalangeal (MTP) joint arthrodesis for hallux rigidus will be measured using a self-reported questionnaire of patient concerns using open ended questions, and the American Orthopaedic Foot and Ankle (AOFAS) Hallux Metatarsophalangeal-Interphalangeal (MTP-IP) scale. Participants will be assessed at two weeks, 6 weeks and three months following surgery.
Sponsors
Mr Andrew Beischer
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Diagnosed with hallux rigidus of grade 1 or greater following plain film X-ray, identified as having undergone an isolated 1st MTP joint arthrodesis in the senior author's private foot and ankle practice within the previous two weeks, no other symptomatic condition of the foot or ankle, discharged from care following successful healing from surgery, consent to participate in the study.
Exclusion criteria
patients with peripheral neuropathy, diabetes mellitus, inflammatory arthritis, neuromuscular disease, concomitant arthritis located elsewhere in the foot and those who had previously undergone arthrodesis surgery on the same joint
Outcome results
None listed